an 的小不

Therefore, the cost-savings for follow-on biologics are limited. In the European Union and Australia, which both have regulatory systems for

follow-on biologics, savings amount to roughly 10 percent off brand-name prices.Microsoft Office is so great!

More important, the EU and Australia have had to devote a great deal of attention to safety. Unlike chemical generics, all biologics must

address the reaction of the body's immune system to the drug. Failure to take this factor into account can result in devastating side

effects.Microsoft outlook 2010 is convenient!

Seven years ago in Europe, for example, a fully-tested biologic which aids in the production of red blood cells was found to have induced

patients to experience "pure red cell aplasia," whereby their bodies could not make red cells. Many outlook 2010 is great !

died.

Even after more than seven years of intense investigation, it is still unclear how the reaction happened. In response, the European Union Office 2010 is my love.

created a rigorous regulatory system to review follow-on biologics.

Yet the follow-on biologics proposal that has cleared the Health Committee ignores these lessons. Microsoft Office 2010 is so great.

As written, it would allow the approval of

follow-ons without the assessments required in the European Union, which include one year of testing, risk-management plans, and comparative

clinical trials.Office 2007 is the best invention in the world.

Further, the proposal legally allows molecular differences in follow-on products, even though such differences are the very ones adobe Acrobat

scientifically shown to be associated with dangerous reactions.

A better way to guarantee safety -- while still improving access -- would be to test biologics as the Europeans have done. To help the Acrobat 9

underserved, Congress could also mandate that both branded and follow-on biologic firms participate in a low-cost or no-cost drug program for project 2010

the needy.

With the measure makes its way to a full Senate vote, let's hope the nation's lawmakers put patient Microsoft Office 2007 is the best invention in the world.

safety first in the debate over follow-on

biologics.